Mucopolysaccharidosis VII
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Identification of embryonic lethal genes in humans by autozygosity mapping and exome sequencing in consanguineous families.
|
26036949 |
2015 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mucopolysaccharidosis type VII (MPS VII) is an inherited disease caused by beta-glucuronidase (beta-glu) deficiency.
|
11906211 |
2002 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Low enzymatic activity can be related to a non-pathological 'pseudodeficiency' allele for beta-glucuronidase; this woman appears to be an apparent compound heterozygote for this allele and mucopolysaccharidosis VII.
|
1779649 |
1991 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The low beta-glucuronidase activity in another mild MPS VII patient was due to reduced biosynthesis of stable mRNA from one allele, and a W446X mutation on the second.
|
9490302 |
1998 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
We have used the beta-glucuronidase-deficient mouse model of mucopolysaccharidosis type VII (MPS VII) to develop an alternative approach to therapy.
|
11044913 |
2000 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
We used reverse-transcription-PCR-SSCP and direct sequencing to screen for mutations in the human beta-glucuronidase cDNA of 17 MPS VII patients with severe presentation of the disease.
|
8644704 |
1996 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
We report on a 20-year-old male with a beta-glucuronidase (GUSB) deficiency mucopolysaccharidosis.
|
1456283 |
1992 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Mutational analysis of a patient with mucopolysaccharidosis type VII, and identification of pseudogenes.
|
7680524 |
1993 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A point mutation which occurred in the human beta-glucuronidase gene in a patient with mucopolysaccharidosis type VII was also conserved.
|
1318788 |
1992 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
MGD |
Transgenic mice homozygous for the mucopolysaccharidosis VII mutation expressed high levels of human beta-glucuronidase activity in all tissues examined and were phenotypically normal.
|
2111021 |
1990 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The beta-glucuronidase (GUSB) mutation of the mucopolysaccharidosis type VII (MPSVII) mouse was backcrossed onto the nonobese diabetic/severe combined immunodeficient (NOD/SCID) xenotransplantation strain.
|
12406886 |
2003 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Dogs with mucopolysaccharidosis VII (MPS VII) were injected intravenously at 2-3 days of age with a retroviral vector (RV) expressing canine beta-glucuronidase (cGUSB).
|
12232044 |
2002 |
Mucopolysaccharidosis VII
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
|
10022533 |
1999 |
Mucopolysaccharidosis VII
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Four novel mutations in mucopolysaccharidosis type VII including a unique base substitution in exon 10 of the beta-glucuronidase gene that creates a novel 5'-splice site.
|
7633414 |
1995 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mucopolysaccharidosis type VII (MPS VII) is caused by the deficiency of the lysosomal hydrolase β-glucuronidase.
|
20864369 |
2010 |
Mucopolysaccharidosis VII
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Adenovirus-mediated gene transfer and expression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice.
|
9037045 |
1997 |
Mucopolysaccharidosis VII
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
To clarify the cross-correction of GUSB secreted from mAEC, the conditioned medium containing high levels of GUSB was added into the medium for culturing human or murine fibroblasts established from an MPSVII patient or a mouse model of the disease.
|
11549068 |
2001 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
To achieve this, we injected AxCAhGUS and AxCACTLA-4Ig into MPSVII mice.
|
10933961 |
2000 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mucopolysaccharidosis type VII (MPS VII) is characterized by deficient β-glucuronidase (GUSB) activity, which leads to accumulation of chondroitin, heparan and dermatan sulfate glycosaminoglycans (GAGs), and multisystemic disease.
|
22513347 |
2012 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
We stereotactically injected an AAV vector containing the human beta-glucuronidase cDNA into the striatum of adult mice severely affected by mucopolysaccharidosis type VII at the time of treatment.
|
10933913 |
2000 |
Mucopolysaccharidosis VII
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Biochemical basis of the beta-glucuronidase gene defect causing canine mucopolysaccharidosis VII.
|
9987917 |
1999 |
Mucopolysaccharidosis VII
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Mucopolysaccharidosis type VII is a lysosomal storage disease resulting from a deficiency of beta-glucuronidase (BG) activity.
|
3924735 |
1985 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Molecular basis of mucopolysaccharidosis type VII: replacement of Ala619 in beta-glucuronidase with Val.
|
2115490 |
1990 |
Mucopolysaccharidosis VII
|
1.000 |
Biomarker
|
disease |
BEFREE |
Neonatal dogs with mucopolysaccharidosis VII (MPS VII) received an i.v.injection of an RV containing the canine beta-glucuronidase (cGUSB) cDNA.
|
11829521 |
2002 |